Clínica Baviera, S.A. (FRA:D9Z)

Market Cap	755.77M
Revenue (ttm)	296.76M
Net Income (ttm)	40.48M
Shares Out	n/a
EPS (ttm)	2.53
PE Ratio	18.67
Forward PE	n/a
Dividend	1.27 (2.83%)
Ex-Dividend Date	Jun 11, 2025

Volume	1
Average Volume	48
Open	44.60
Previous Close	45.10
Day's Range	44.60 - 45.00
52-Week Range	29.80 - 46.50
Beta	n/a
RSI	63.99
Earnings Date	Nov 21, 2025

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, lasek, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. an...

• Industry: Health Services
• Founded: 1992
• Employees: 1,759
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: D9Z

Financial Performance

In 2024, Clínica Baviera's revenue was 265.72 million, an increase of 17.02% compared to the previous year's 227.07 million. Earnings were 40.21 million, an increase of 11.77%.